Perrigo Settles With Cadence Over Ofirmev Generic Plans
Generic-drug maker Perrigo Co. and its subsidiary Paddock Laboratories LLC have entered into a licensing agreement with Cadence Pharmaceuticals Inc., ending a Delaware patent dispute over Paddock's plans to make a...To view the full article, register now.
Already a subscriber? Click here to view full article